Grifols SA
MAD:GRF
Grifols SA
MAD:GRF
Price:
8.888 EUR
2.8%
Market Closed
Updated:
May 2, 2024
Grifols SA
Revenue
|
Grifols SA
Revenue Peer Comparison
Comparables:
ORY
PHM
BST
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Grifols SA
MAD:GRF
|
Revenue
€6.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Oryzon Genomics SA
MAD:ORY
|
Revenue
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pharma Mar SA
MAD:PHM
|
Revenue
€158.2m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
Biotechnology Assets SA
MAD:BST
|
Revenue
€3.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
Grifols SA
Revenue Breakdown
Breakdown by Geography
Grifols SA
Grifols SA
|
Total Revenue:
6.6B
EUR
|
|
Usa And Canada:
3.2B
EUR
|
|
Rest Of The World:
872.1m
EUR
|
|
European Union:
544m
EUR
|
|
Spain:
362.4m
EUR
|
Breakdown by Segments
Grifols SA
Grifols SA
|
Total Revenue:
6.6B
EUR
|
|
Haemoderivatives:
3.8B
EUR
|
|
Transfusional Medicine:
712.2m
EUR
|
|
Bio Supplies:
225.8m
EUR
|
|
Hospital Supplies:
70.2m
EUR
|
|
Fluid Therapy And Nutrition:
46.7m
EUR
|
|
Other Product:
39.6m
EUR
|
|
Other Diagnostic:
23.6m
EUR
|
See Also
What is Grifols SA's Revenue?
Revenue
6.6B
EUR
6.6B
EUR
Based on the financial report for Dec 31, 2023, Grifols SA's Revenue amounts to 6.6B EUR.
What is Grifols SA's Revenue growth rate?
Revenue CAGR 5Y
8%
8%
Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for Grifols SA have been 7% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
